Pelvic Girdle Pain Early Postpartum: Underlying Condition and Associated Factors

May 11, 2021 updated by: Żelazna Medical Centre, LLC

Background: Pregnancy-related pelvic girdle pain (PGP) can appear during pregnancy, directly after labour or can be delayed to 3 weeks postpartum. Pain is experienced between the posterior iliac crest and the gluteal fold, particularly in the vicinity of the Sacroiliac joints (SIJ). The pain may radiate in the posterior thigh and can also occur in conjunction with/or separately in the symphysis. The endurance capacity for standing, walking, and sitting is diminished. The diagnosis of PGP can be reached after exclusion of lumbar causes. The pain or functional disturbances in relation to PGP must be reproducible by specific clinical tests. Lack of accurate and early diagnosis of the PGP reasons postpartum may contribute to development of chronic condition, lowering quality of life years after delivery.

Objectives: The aim of the project is to evaluate the underlying cause of the severe pelvic girdle pain postpartum (whether it is real PGP or diastasis pubic symphysis) and to assess the differences between females with severe postpartum PGP, mild and moderate PGP and with no PGP in terms of: presence of diastasis pubic symphysis, presence of diastasis recti and linea alba dysfunction, factors associated with labour and maladaptive mental processing (catastrophizing).

Materials and methods: Because of low incidence of researched conditions, a case control study will be the study design of choice. The subjects with PGP will be matched with those with no PGP. Subjects' assessment will consist of palpation and ultrasonography evaluation of diastasis recti(inter-recti distance), ultrasonography assesment of pubic symphysis (inter-pubic width) and mental processing (catastrophizing assessed with Pain Catastrophizing Scale) analysis. Factors connected with labour (time from epidural anaesthesia injection to full dilatation and delivery) will be also investigated.

Expected results: To the investigators' knowledge, postpartum pelvic girdle pain has not been extensively studied so far. The study will bring information about the possible underlying cause of postpartum PGP: whether it is PGP or diastasis pubic symphysis.

Study Overview

Study Type

Observational

Enrollment (Actual)

105

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mazowieckie
      • Warsaw, Mazowieckie, Poland, 01-004
        • Centre of Postgraduate Medical Education

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women in early postpartum period (during hospital stay)

Description

Inclusion Criteria:

  • Natural labour or vacuum extractor or forceps
  • for the study group - pain due to PGP confirmed with dedicated functional tests
  • for control group with no pain - no pain due to PGP
  • agreement to participate

Exclusion Criteria:

  • diseases that can mimic PGP f.ex. Scheuermann disease, rheumatoid arthritis, Ehler's-Danlos Syndrome, hip dysplasia
  • major peri-partum events like internal haemorrhage, pelvic fracture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
PGP
Patients in early postpartum period experiencing PGP, confirmed with dedicated functional tests
no PGP
Patients in early postpartum period, with no symptoms and signs of PGP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diastasis Recti: ultrasound measurement of inter-recti distance
Time Frame: one time assessment, during the hospital stay, within 1st week postpartum
measurement of inter-recti distance (ultrasound assessment at the level of umbilicus, 2cm over the umbilicus and 2 cm below)
one time assessment, during the hospital stay, within 1st week postpartum
Pubic symphysis distance
Time Frame: one time assessment, during the hospital stay, within 1st week postpartum
assesment of pubic symphysis distance - presence of diastasis pubic symphysis, distance measured by ultrasound
one time assessment, during the hospital stay, within 1st week postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Catastrophizing Scale
Time Frame: one time assessment, during the hospital stay, within 1st week postpartum
Assesment of Catastrophizing
one time assessment, during the hospital stay, within 1st week postpartum
Epidural anaesthesia
Time Frame: during labour (Time form injection to full cervical dilatation)
Time form injection to full cervical dilatation
during labour (Time form injection to full cervical dilatation)
Epidural anaesthaesia2
Time Frame: during labour (Time form injection to labour)
Time form injection to labour
during labour (Time form injection to labour)
Diastasis Recti: inter-recti distance
Time Frame: one time assessment, during the hospital stay, within 1st week postpartum
measurement of inter-recti distance by palpation examination at the level of umbilicus, 2cm over the umbilicus and 2 cm below
one time assessment, during the hospital stay, within 1st week postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

February 25, 2021

Study Completion (Actual)

February 25, 2021

Study Registration Dates

First Submitted

February 4, 2019

First Submitted That Met QC Criteria

February 7, 2019

First Posted (Actual)

February 8, 2019

Study Record Updates

Last Update Posted (Actual)

May 14, 2021

Last Update Submitted That Met QC Criteria

May 11, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Girdle Pain

3
Subscribe